The Medical University of Vienna is a public university located in Vienna, Austria. It is the direct successor to the faculty of medicine at the University of Vienna, founded in 1365 by Rudolf IV, Duke of Austria.

During the past decade, Medizinische Universität Wien (Adults only) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Medizinische Universität Wien (Adults only)" are "Allogeneic Hematopoietic Cell Transplant" (2 trials), "Lymphoproliferative Disorders" (2 trials), "Solid Organ Transplant Complications" (2 trials), "Stem Cell Transplant Complications" (2 trials) and "Chronic Active Epstein-Barr Virus (CAEBV)" (1 trials). Many other conditions were trialed in "Medizinische Universität Wien (Adults only)" in a lesser frequency.

Most popular intervention types in "Medizinische Universität Wien (Adults only)" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Tabelecleucel" (1 trials) and "tabelecleucel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medizinische Universität Wien (Adults only)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Medizinische Universität Wien (Adults only)". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Medizinische Universität Wien (Adults only), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medizinische Universität Wien (Adults only), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".